RESUMO
BACKGROUND: The purpose of this study was to evaluate the long-term safety of the Igaki-Tamai stent, the first-in-human fully biodegradable coronary stent made of poly-l-lactic acid. METHODS AND RESULTS: Between September 1998 and April 2000, 50 patients with 63 lesions were treated electively with 84 Igaki-Tamai stents. Overall clinical follow-up (>10 years) of major adverse cardiac events and rates of scaffold thrombosis was analyzed together with the results of angiography and intravascular ultrasound. Major adverse cardiac events included all-cause death, nonfatal myocardial infarction, and target lesion revascularization/target vessel revascularization. During the overall clinical follow-up period (121 ± 17 months), 2 patients were lost to follow-up. There were 1 cardiac death, 6 noncardiac deaths, and 4 myocardial infarctions. Survival rates free of all-cause death, cardiac death, and major adverse cardiac events at 10 years were 87%, 98%, and 50%, respectively. The cumulative rates of target lesion revascularization (target vessel revascularization) were 16% (16%) at 1 year, 18% (22%) at 5 years, and 28% (38%) at 10 years. Two definite scaffold thromboses (1 subacute, 1 very late) were recorded. The latter case was related to a sirolimus-eluting stent, which was implanted for a lesion proximal to an Igaki-Tamai stent. From the analysis of intravascular ultrasound data, the stent struts mostly disappeared within 3 years. The external elastic membrane area and stent area did not change. CONCLUSION: Acceptable major adverse cardiac events and scaffold thrombosis rates without stent recoil and vessel remodeling suggested the long-term safety of the Igaki-Tamai stent.
Assuntos
Implantes Absorvíveis/estatística & dados numéricos , Doença da Artéria Coronariana/mortalidade , Doença da Artéria Coronariana/terapia , Ácido Láctico , Revascularização Miocárdica , Polímeros , Stents/estatística & dados numéricos , Idoso , Biópsia , Estudos de Coortes , Angiografia Coronária , Doença da Artéria Coronariana/diagnóstico , Trombose Coronária/diagnóstico , Trombose Coronária/mortalidade , Trombose Coronária/prevenção & controle , Ecocardiografia , Feminino , Seguimentos , Humanos , Pacientes Internados/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/diagnóstico , Infarto do Miocárdio/mortalidade , Infarto do Miocárdio/terapia , Revascularização Miocárdica/instrumentação , Revascularização Miocárdica/métodos , Revascularização Miocárdica/mortalidade , Pacientes Ambulatoriais/estatística & dados numéricos , Inibidores da Agregação Plaquetária/uso terapêutico , Poliésteres , Estudos Prospectivos , Análise de Sobrevida , Fatores de Tempo , Ultrassonografia de IntervençãoAssuntos
Átrios do Coração/patologia , Neoplasias Cardíacas/diagnóstico , Hemangioma/diagnóstico , Derrame Pericárdico/diagnóstico , Adulto , Feminino , Átrios do Coração/cirurgia , Neoplasias Cardíacas/complicações , Neoplasias Cardíacas/cirurgia , Hemangioma/complicações , Hemangioma/cirurgia , Humanos , Derrame Pericárdico/etiologia , Derrame Pericárdico/cirurgiaAssuntos
Implantes Absorvíveis , Doença da Artéria Coronariana/terapia , Ácido Láctico , Polímeros , Stents , Alicerces Teciduais/tendências , Idoso de 80 Anos ou mais , Autopsia , Vasos Coronários/patologia , Humanos , Masculino , Intervenção Coronária Percutânea , Poliésteres , Fatores de Tempo , Resultado do TratamentoRESUMO
Recurrent varicose veins are considered to be caused by the recurrence of reflux but rarely may be secondary to other pathologies. A 39-year-old man complained of right lower leg skin pigmentation, pain and fatigue for several years. Duplex ultrasound revealed that the great saphenous vein diameter at the saphenofemoral junction level was 7.7 cm, and at the knee medial level was 14.4 cm. The reflux time at the proximal great saphenousvein level was 1.85 s. Endovenous laser ablation for dilated and refluxed great saphenous vein was performed. However, 1 year later, the symptoms recurred. Duplex ultrasound suspected abnormal arterial flow from the right superficial femoral artery to the recanalized segment of previously ablated great saphenous vein and anterior accessory saphenous vein. One month later, despite the successful re-endovenous laser ablation, the symptoms recurred. Computed tomography angiography showed three fistulous vessels from superficial femoral artery to anterior accessory saphenous vein. Combined treatments with endovenous laser ablation and coil embolization was performed. Ultimately, the fistulas were obliterated and the patient remained free of symptoms. Varicose veins due to the fistulas from superficial femoral artery are rare and difficult to diagnose but can be entirely treated with the percutaneous approach.
RESUMO
OBJECTIVE: The combination of endovenous therapies with stab avulsion or ultrasound guided foam sclerotherapy is widely performed. However, these conventional techniques tend to result in incomplete avulsions or persistent varicosities. METHODS: One hundred and thirteen legs in 97 consecutive patients who underwent 1470 nm laser ablation for great saphenous varicose veins were enrolled. The foam sclerosing agent was injected via the sheath after endovenous laser ablation (EVLA). Patients were divided into two groups: EVLA only group (Control; n = 50) and EVLA and transluminal injection of foam sclerotherapy (TLFS) group (SCL; n = 63). RESULTS: At three month follow up, reflux was abolished throughout all treated great saphenous veins (GSVs) when assessed with Duplex ultrasound. Thrombophlebitis was observed in two patients in the SCL group (p = .13). Additional second stage sclerotherapy was needed in the Control group (n = 33, 66%) vs. SCL group (n = 2, 3%; p < .0001). The venous clinical severity score (VCSS) was significantly improved in the SCL group (changes of VCSS, Control -3.3 ± 1.7 and SCL -4.4 ± 1.0; p < .0001). Univariable and multivariable analyses revealed that, among age, sex, Clinical-Etiology-Anatomy-Pathophysiology classification, linear endovenous energy density, and TLFS, TLFS was the only significant factor of improved VCSS (hazard ratio = -0.96; 95% confidence interval = -1.4 to -0.58; p < .0001). CONCLUSIONS: TLFS combined with EVLA may be an easy, safe, and effective procedure with acceptable complications vs. EVLA alone and reduces additional second stage interventions.
RESUMO
Cine mode magnetic resonance (MR) imaging has allowed evaluation of kinematics of the pelvis. Visualization of dynamic changes under strain facilitates evaluation of prolapses and adhesions between organs. The uterus, an organ of smooth muscle, has an inherent contractility that characterizes it as different from other visceral organs. This sustained contraction has occasionally been shown on static images as a finding masquerading as a leiomyoma or as adenomyosis. Cine mode MR imaging clearly shows the configuration of the myometrium during these dynamic changes, as well as its signal intensity during contractions. Uterine peristalsis, the subtle and rhythmic contractions of the inner myometrium, is also clearly identifiable on cine mode images as a wavy movement of the endometrium and/or inner myometrium. The direction and frequency of uterine peristalsis are different in each of the menstrual cycle phases and are thought to have important roles in uterine function, such as in fertility and menstrual blood discharge. Elucidation of these kinematics of the uterus will help in the evaluation of static MR images and study of the physiology of the uterus. Cine MR imaging is a novel technique for diagnosis and evaluation of the pelvic organs, especially the uterus.
Assuntos
Imagem Cinética por Ressonância Magnética/métodos , Útero/fisiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Fenômenos Biomecânicos , Ritmo Circadiano , Dismenorreia/diagnóstico , Feminino , Humanos , Leiomioma/diagnóstico , Ciclo Menstrual/fisiologia , Pessoa de Meia-Idade , Diafragma da Pelve , Doença Inflamatória Pélvica/complicações , Doença Inflamatória Pélvica/diagnóstico , Valores de Referência , Estresse Mecânico , Aderências Teciduais/diagnóstico , Aderências Teciduais/etiologia , Neoplasias Uterinas/diagnósticoRESUMO
Recently, drug-eluting stent (DES) has been recommended as the first choice in those patients who need stent implantation in unprotected left main coronary artery (ULMCA) stenosis. However, the long-term safety and efficacy of this procedure is still controversial. The objective of this study was to evaluate the safety and efficacy of bare metal stent (BMS) implantation in ULMCA stenting in the DES era. We implanted BMS (mainly 4 mm-diameter) in large-sized ULMCA after December 2004 when DES became available. The results of BMS implantation (n = 19) were compared with those of DES implantation (n = 39). There was no significant difference between the 2 groups regarding age, gender and coronary risk factors. Emergency procedures were more frequently performed in the BMS group than in the DES group (53% vs. 26%, p = 0.08). The initial mortality was 10.5% (n = 2) in the BMS group and 2.6% (n = 1) in the DES group (p = 0.25). There was no stent thrombosis, Q-wave myocardial infarction or emergent bypass surgery in either group during their hospital stay. The restenosis rate was 0% (n = 45) in both groups, and the target vessel revascularization rate was 5.9% in the BMS group (1/17) and 2.6% (1/38) in the DES group (p = 0.53). Therefore, there were no statistically significant differences in outcomes between the two study groups. These results indicate that BMS implantation in a large-sized ULMCA may be a safe and effective treatment even in the DES era.